ZIOPHARM Oncology, Inc. (ZIOP) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Chris Taylor - Vice President, Investor Relations and Corporate Communications Laurence Cooper - Chief Executive Officer Satyavrat Shukla - Chief Financial Officer David Mauney - President Conference Call Participants Alethia Young - Cantor Fitzgerald David Novak - Raymond James Ramakanth Swayampakula - H.C. Wainwright & Co., LLC Thomas Flaten - Lake Street Capital Markets, LLC Yale Jen - Laidlaw & Co ...

First Quarter 2020 Financial Results and Update 07 May 2020 Forward Looking Statements This presentation contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as "may," "will," "could," "expects," "plans," "anticipates," and "believes." These statements include, but are not limited to, statements regarding the Company's busin ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-33038 ZIOPHARM Oncology, Inc. (Exact name of registrant as specified in its charter) Delaware 84-1475642 (State or other jurisdiction of incorpo ...

Fourth Quarter and Full Year 2019 Results Call 02 March 2020 Forward Looking Statements This presentation contains certain forward-looking information about Ziopharm Oncology, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as "may," "will," "could," "expects," "plans," ...

ZIOPHARM Oncology, Inc. (ZIOP) Q4 2019 Results Conference Call March 2, 2020 4:30 PM ET Company Participants Chris Taylor - Vice President, Investor Relations and Corporate Communications Laurence Cooper - Chief Executive Officer Sath Shukla - Executive Vice President, Chief Financial Officer David Mauney - President Conference Call Participants Yale Jen - Laidlaw & Company Thomas Flaten - Lake Street Capital Swayampakula Ramakanth - H.C. Wainwright Nick Abbott - Wells Fargo Operator Ladies and gentlemen, t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Delaware 84-1475642 (State or Other Jurisdiction of Incorporation or Organization) One First Avenue, Parris Building 34, Navy Yard Plaza Boston, Massachusetts 02129 (Address of Principal Executive Offices) (Zip Code) FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHA ...

38th Annual JP Morgan Healthcare Conference 16 January 2020 Forward Looking Statements This presentation contains certain forward-looking information about Ziopharm Oncology, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as "may," "will," "could," "expects," "plans," " ...

| --- | --- | |---------------------------------------------|-------| | | | | | | | | | | | | | Third Quarter Results and Corporate Update | | | November 7, 2019 | | Forward Looking Statement 2 This presentation contains certain forward-looking information about Ziopharm Oncology, Inc. that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historica ...

ZIOPHARM Oncology, Inc. (ZIOP) Q3 2019 Earnings Conference Call November 7, 2019 4:30 PM ET Company Participants Chris Taylor - Vice President of Investor Relations and Corporate Communications Dr. Laurence Cooper - Chief Executive Officer Dr. David Mauney - President Satyavrat Shukla - Chief Financial Officer Conference Call Participants David Novak - Raymond James Thomas Flaten - Lake Street Capital Sean Lee - H.C. Wainwright Operator Good afternoon, ladies and gentlemen. Thank you for standing by and wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Securities registered pursuant to Section 12(b) of the Act: For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE A ...